Paul Tudor Jones's AZN Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 39,286 shares of AstraZeneca PLC (AZN) worth $3.01 M, representing 0.01% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in AZN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2022, adding 38,553 shares. Largest reduction occurred in Q4 2022, reducing 69,209 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +54,200 | New Buy | 54,200 | $37.16 |
| Q3 2014 | -54,200 | Sold Out | 54,200 | $0.00 |
| Q3 2022 | +92,753 | New Buy | 92,753 | $54.84 |
| Q4 2022 | -69,209 | Reduce 74.62% | 23,544 | $0.07 |
| Q1 2023 | -23,544 | Sold Out | 23,544 | $0.00 |
| Q3 2023 | +6,473 | New Buy | 6,473 | $67.72 |
| Q4 2023 | -6,473 | Sold Out | 6,473 | $0.00 |
| Q4 2024 | +32,100 | New Buy | 32,100 | $65.52 |
| Q1 2025 | +3,176 | Add 9.89% | 35,276 | $73.50 |
| Q2 2025 | +35,899 | Add 101.77% | 71,175 | $69.88 |
| Q3 2025 | -31,889 | Reduce 44.80% | 39,286 | $76.72 |
Paul Tudor Jones's AstraZeneca PLC Investment FAQs
Paul Tudor Jones first purchased AstraZeneca PLC (AZN) in Q2 2014, acquiring 54,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held AstraZeneca PLC (AZN) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to AstraZeneca PLC (AZN) was in Q3 2022, adding 92,753 shares worth $5.09 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 39,286 shares of AstraZeneca PLC (AZN), valued at approximately $3.01 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in AstraZeneca PLC (AZN) was 92,753 shares, as reported at the end of Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.